checkAd

     217  0 Kommentare TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment - Seite 3

    For more information, please contact:

    TransCode Therapeutics, Inc.
    Tania Montgomery-Hammon, Business Development
    tania.montgomery@transcodetherapeutics.com



    globenewswire
    0 Follower
    Autor folgen
    Seite 3 von 3

    Verfasst von globenewswire
    TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment - Seite 3 BOSTON, March 11, 2024 (GLOBE NEWSWIRE) - TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, reported positive proof-of-concept laboratory studies in human …